Authors


Julie Kennedy Oehlert, DNP

Latest:

Nurse Leaders Incorporate More Kindness Into Their Work to Combat Burnout

As part of an ambitious plan to transform the culture at Vidant Health and improve the experience of patients and team members alike, Oehlert helped reframe the organization’s goals to consider kindness and compassion as part of strategic excellence.


Robert Fisher, MD

Latest:

Navigating Breast Cancer Survivorship: Sustaining the Good News

Forty years after the declaration of war on cancer, one of the most profound shifts in cancer care today is a new focus on treating those living beyond cancer, as well as those living with cancer.


Amita Patel, NPC

Latest:

Amita Patel on the Benefits of a Multidisciplinary Care Team

Amita Patel, NPC, Regional Cancer Care Associates, Central Jersey Division, talks about benefits of a multidisciplinary care team and some issues that providers should be aware of when treating patients undergoing chemotherapy.


Kathy LaTour

Latest:

Camping for Health

Jackie Miller, BSN, RN, OCN, works to provide emotional support for children whose parents have cancer.


Karen Selby, RN

Latest:

Chronic Pain and Policy Restrictions: Controversies Holding Back Effective Pain Management

Patients with cancer are faced with chronic pain that nurses often cannot manage properly due to outdated restrictions and practices.


Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN
Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN

Latest:

What’s the Difference: Biologics vs Biosimilars in Cancer Care

Nurses play an important role in the administration of biosimilars and the education of patients receiving them.


Jonathan S. Batchelor

Latest:

Metformin May Decrease Diabetics' Breast Cancer Risk

In postmenopausal diabetic women, metformin use was associated with lower ER and PR breast cancer incidence.


Paula Raska

Latest:

Paula Raska Discusses Patient Navigation Through Cancer Care

Paula Raska, a research associate from the Cleveland Clinic, discusses a study of patient navigation.


Ginger Hanson, PhD, MS

Latest:

Helping Patients Manage Work-Life Balance During and After Treatment

During and after treatment, the majority of patients will be back at their jobs sometime after diagnosis and treatment, but that doesn’t have to come with emotional distress if possible outcomes are discussed.


Jonathan Alicea

Latest:

New Discoveries in AML Treatments Bring Hope

Expert Jeffrey Lancet, MD, discusses the emerging agents in treating acute myeloid leukemia (AML) and challenges that still exist for improving patient outcome.


Mary Lou Woodford, RN, BSN, MBA, CCM

Latest:

Mary Lou Woodford on CoC Accreditation Compliance

Mary Lou Woodford, from the Cancer Resource Foundation, provides guidance on staying compliant with the new patient navigation accreditation standards from the American College of Surgeons Commission on Cancer.


Aditya Bardia, MD, MPH

Latest:

Oral Elacestrant Requires Patient Education in Metastatic ER+ Breast Cancer

Nausea and upper GI discomfort are frequently linked with use of the oral SERD.


Kathryn H. Schmitz, PhD, MPH

Latest:

Kathryn H. Schmitz Answers: What Can Mouse Studies Offer Human Research?

Kathryn H. Schmitz, PhD, MPH, professor of Public Health Sciences and associate director of Population Sciences at the Penn State Cancer Institute, discusses benefits that can be reaped from running parallel mouse and human studies.


Katie Brown

Latest:

Lung Cancer-5 Reasons to be Hopeful

The month of May is Lung Cancer Hope Month, and here are just 5 reasons we can all be hopeful.


Cori Carl

Latest:

Surviving the ER

Being a caregiver in the ER is usually pretty awful. It feels like I'm always in the way.


Beth Sandy, MSN, CRNP

Latest:

Beth Sandy on Incorporating Amivantamab and Mobocertinib into Clinical Practice for Patients With EGFR Exon 20 Insertion NSCLC

Beth Sandy, MSN, CRNP, discusses the application of 2 FDA approved drugs for patients with non–small cell lung cancer and an exon 20 insertion mutation.


Kristie Rosa

Latest:

Cabozantinib/Atezolizumab Shows Promise in Treating Advanced HCC

A combination of cabozantinib and atezolizumab improved the PFS in patients with Advanced HCC


Chelsea LoCascio

Latest:

Expert Discusses the Present and Future of Genetic Testing in Breast Cancer

Laura J. van’t Veer, PhD, discussed determining more accurate methods of treatment for patients with early- and late-state breast cancer based on advances in genetic testing, specifically the 70-gene prognostic signature.


Rebecca Sutphen, MD

Latest:

Dr. Sutphen Discusses Insurance Coverage of Genetic Counseling and Testing

Rebecca Sutphen, MD, from the University of South Florida, discusses the importance of connecting patients with clinical trials.


Amir Khan, MD

Latest:

Disparities Exist in Younger Adults With GI Cancers

There are socioeconomic and ethnic disparities in young adults who receive a diagnosis of colorectal and gastric cancers, according to Amir Khan, MD, from City of Hope.


Theresa Wicklin Gillespie, PhD, MA, RN, FAAN, Emory University

Latest:

Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric Cancer

Shared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.


Leslie M. Randall, MD, MAS

Latest:

Combinations May Combat PARP Resistance

Combining PARP inhibitors with another kind of agent may be key in overcoming resistance.


Alix Beaupierre, RN, BSN, OCN

Latest:

Alix Beaupierre on Patient Education for CAR T-cell Therapy Clinical Trials

Alix Beaupierre, RN, BSN, OCN, Moffitt Cancer Center, explains the patient education program created for a recent CAR T-cell therapy clinical trial.



Jessica Ryan, MD

Latest:

Dr. Jessica Ryan on the Role of Nurses in Extreme Oncoplasty

Jessica Ryan, MD, breast surgeon, Elliot Breast Health Center, Manchester, New Hampshire, discusses the role of oncology nurses in extreme oncoplasty.



Patrick Spencer, RN, OCN

Latest:

Patrick Spencer on Preparing Patients with Multiple Myeloma for Daratumumab Treatment

Patrick Spencer, RN, OCN provides important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.


Mark Lazenby, PhD, APRN, FAPOS

Latest:

Mark Lazenby on Psychosocial Topics Concerning APOS

Mark Lazenby, PhD, APRN, FAPOS, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses psychosocial topics that concern APOS.


Ruth McCorkle

Latest:

Enhancing Peer Review to Support APN Practice

Yale-New Haven Hospital (YNHH) currently credentials more than 400 advanced practice nurses (APNs) who practice in a wide range of roles and geographic locations. The number of practitioners more than doubled in the past 3 years, and now more than 50 APNs are practicing in oncology in Smilow Cancer Hospital at YNHH and at community care centers.


Christian Capitini, MD

Latest:

Christian Capitini on Response to Immunotherapy

Christian Capitini discusses the responses to immunotherapy.